Definitive Contract HDTRA121C0033

Award Date 9/20/21
Potential Completion Date 9/19/26
Potential Value $2.7M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Gainesville, FL 32611, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
20
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The University of Florida (UF) Division of Sponsored Research was awarded a Firm Fixed Price Delivery Order contract from the Office of Acquisitions and Grants, a civilian federal agency, with a ceiling value of $1,624. The contract, which does not have a set-aside designation, is for Task Order 8 under a larger Indefinite Delivery Contract (IDC) with the National Institute of Allergy and Infectious Diseases (NIAID). This IDC, valued at $146.3 million over 7 years, supports the development and...
This is a firm fixed-price Purchase Order contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to the University of Florida (UF) Division of Sponsored Research, a major research institution, for the "AFRICAN ANTHRAX MAPPING PROJECT". The $130,775 contract has an ultimate completion date of January 15, 2017 and is not set aside. The University of Florida has extensive research capabilities across numerous disciplines, including science,...
The University of Florida was awarded a definitive firm fixed price contract valued at $454,657.16 by the Department of Homeland Security Science and Technology Directorate. The scope of work is a proof-of-principle study to demonstrate the potential for human adeno-associated virus gene therapy vectors to impart sustained expression of classical swine fever virus neutralizing monoclonal antibody in pigs and protection against classical swine fever. Kansas State University and the University...
The University of Florida (UF) Division of Sponsored Research has been awarded a Firm Fixed Price Delivery Order contract by the Office of Acquisitions and Grants, a civilian agency, with a ceiling value of $2,072.00. The contract, Task Order 9 Modification G0321D0007, has an ultimate completion date of January 20, 2025. This contract award is not associated with any set-aside designation. UF, a major research institution, has a broad portfolio of federal contract and grant awards supporting...
The Department of the Air Force Materiel Command Research Laboratory has awarded a $430,827.00 delivery order contract to the University of Florida's Division of Sponsored Research for "NETWORK-AWARE COORDINATION FOR MULTI-AGENT SYSTEMS WITH LIMITED COMMUNICATION AND COMPUTATION". This is not a set-aside contract. The University of Florida is a public land-grant research institution that conducts extensive research and provides technical services to various U.S. government agencies,...
This federal contract award to Colorado State University, a public land-grant university, is to develop and manufacture an inactivated virus vaccine using blood pathogen reduction technology to address COVID-19. The award, valued at $19,218,003, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), under a broader NIAID Omnibus Broad Agency Announcement for advanced development of vaccine candidates and therapeutics...
This is a federal contract awarded by the Department of the Air Force Materiel Command Research Laboratory to the University of Florida's Division of Sponsored Research. The $412,818.00 contract is for the development of multi-agent algorithms. The contract does not have a set-aside designation and is a Delivery Order with a Cost No Fee pricing type. The University of Florida is a public land-grant research university that has previously provided research, development, testing, and evaluation...
This is a federal contract award from the Defense Threat Reduction Agency (DTRA), a defense agency, to the University of Texas at Austin (UT Austin), a public research university. The contract, valued at $1,448,665, is for a base period ending on September 30, 2022, with a definitive contract structure and cost-no-fee pricing type. The contract does not have a set-aside designation. UT Austin, as the prime contractor, is responsible for providing research, development, and technical services...
This federal contract award, HSHQDC16CB0012, was issued by the Science and Technology Directorate of the U.S. Department of Homeland Security to the University of Florida (UF) Division of Sponsored Research for $1,492,499.41. The contract is for mapping and modeling Clostridium botulinum across North Africa and the Middle East using high-resolution genetic sequencing and spatial analysis. The contract is a definitive contract with a cost-no-fee pricing type and a period of performance ending...
This is a $206,424.00 firm fixed price definitive contract awarded by the U.S. Department of Health and Human Services to the Southern Research Institute, a non-profit organization, for the evaluation of the efficacy and immunogenicity of a vaccinia virus-based vaccine against Bacillus anthracis (anthrax). The contract does not have a set-aside designation. Southern Research Institute has previously conducted research and provided services related to drug discovery and development, emerging...

The University of Florida Division of Sponsored Research was awarded a $2.7 million definitive cost-no-fee contract by the Defense Threat Reduction Agency to conduct research and development services related to the virulence and protective efficacy of vaccines against antigenically novel Bacillus strains. Under this contract, the prime contractor will collaborate with Colorado State University and the U.S. Army Medical Research Institute of Infectious Diseases to assess the threat posed by emerging anthrax-causing bacteria through animal testing of pathogenicity and vaccine protection. Colorado State University will support tasks including propagating bacterial strains, preparing spores, and evaluating the efficacy of the Sterne vaccine and an experimental CRM-PGA capsule vaccine against various Bacillus anthrax strains. The work will aim to identify threats from new pathogens and investigate an additional antigen to enhance the current anthrax vaccine model. There is no set-aside designation for this contract to the University of Florida, which will be performed over five years in support of the Defense Threat Reduction Agency's biological defense research programs.

Generated 12/29/23, 4:04 PM